Corporate Information
Aqix Ltd is proud of the affiliations formed with many of its customers and trading partners in an endeavour to bring this unique fluid technology to the biomedical industry on a global scale.
Recent events have highlighted the emergence of the company’s fluid technology in applications involving stem cell therapy, organ transplant technology, human tissue storage and transportation and preclinical drug bioassay.
 |
John Morgan, Non-executive Chairman
•Chairman of listed biotechnology company
• Turned own start-up into a £1.2bn turnover listed plc
|
 |
doug@aqix.com
• Inventor and developer of the technology
• Former Senior Lecturer in Neurophysiology, VUW, NZ
• Visiting Senior Research Fellow, Kings College, London |
 |
Matthew Durdy, MBA
Chief Executive
matthew@aqix.com
• MD of International medical product business
• Venture capitalist and investment banker
• Oxford Biologist with Chicago MBA |
| |
Regulatory Affairs - Dr. Wynne Weston-Davies
Financial Officer - Martin Powell |
|